Pancreatic Enzyme Replacement Therapy Shortage

I was diagnosed with bile duct cancer and had a whipple surgery and there were complications during it. As a result, I have to take a high dosage of PERT to eat and was prescribed Creon.

There has been a shortage for the last few months and I’m struggling to get my prescriptions filled. I did recently manage to get a prescription of Pancrex V powder which I’ve never used before.

Has anyone had any experience with it and is anyone also finding it hard to get their PERT prescription?

Parents Reply Children
  • I have a Pancreas NET and Sugeon can’t operate - had awful bowel symptoms with Creon, doseage was 3x25000 with main meals  and 1x 25000 at 3 snacks but couldn’t cope so reduced them to 1 x25000 per meal. Still feel ok.

    Shotrtage of Creon from Pharmacy locally but Dr has sourced another Brand available for me next week. My Side effect of my NET is Diabetes increased by the 4 weekly Lanreotide injection, it was controlled by compliant diet. Struggling with this as not injecting insulin yet.

  • I raised this with my MP recently and received the following response:

     

    The new Government has inherited ongoing global supply problems that continue to affect
    medicine availability in England. We know how frustrating and distressing this can be for
    patients, and we are working closely with industry, the NHS, manufacturers and other
    partners in the supply chain to resolve issues as quickly as possible to make sure patients
    can access the medicines they need.
    There are around 14,000 licensed medicines, and the overwhelming majority are in good
    supply. However, medicine supply chains are complex, global and highly regulated and the
    NHS does occasionally experience temporary shortages of some medicines. There are a
    number of reasons why supply can be disrupted, many of which are not specific to the UK
    and are outside the Government’s control; these include manufacturing difficulties, access
    to raw materials, sudden demand spikes or distribution issues, and regulatory issues.
    Medicine supply issues are global in their nature and, while we cannot always prevent
    them, we have a range of well-established processes and tools to manage them when
    they arise and to mitigate risks to patients. There is a team in the Department that deals
    with medicine supply problems by working closely with the Medicines and Healthcare
    products Regulatory Agency, the pharmaceutical industry, NHS England and others
    operating in the supply chain. We also work with partners to ensure alternative treatments
    are available to patients until their usual treatments are back in stock.
    At the time of writing, we are aware of ongoing intermittent supply issues with pancreatic
    enzyme replacement therapy (PERT), including Creon capsules. These have been caused
    by limited supplies of active pharmaceutical ingredients and manufacturing capacity
    constraints. The supplier of Creon has advised that it expects to have regular supplies
    released each month for the remainder of the year. The Department is continuing to work
    with all suppliers of PERT products to help resolve the issues, expedite deliveries, source
    stock from other markets and increase production.
    We have also issued comprehensive guidance to healthcare professionals, which provides
    advise on how to manage patients while there is disruption to supply. This guidance is
    being kept under review and updated will be made as necessary.
    In addition, serious shortage protocols (SSPs) are in place for Creon 10000 and 25000
    capsules to limit prescriptions to one month’s supply; this is to ensure that Creon remains
    available for those patients who need it. An SSP enables community pharmacists to
    supply a specified medicine or device with the patient’s consent and without needing to
    seek authorisation from the prescriber.
    The Department will continue to work closely with the manufacturers to resolve the issues
    as soon as possible and to ensure patients have continuous access to medicines. If any
    patient is concerned about their treatment, they should discuss this with their clinician at
    the earliest opportunity.

  • I’m glad to see you got a response and it is good to know that they are working on the issue at least.

    Unfortunately, I haven’t received a response from my MSP. Even though they would probably say the same thing, I think I might chase them up regardless.

  • I keep telling myself that this is their job, and that's why we have to keep up the pressure! Although it's not a very enlightening or helpful response. I emailed back, saying how much I appreciated it but also that, no matter how interesting and intricate the reasons are, we cannot eat without this medication, and we simply need it fixed.

    The rumours I have heard is that things should get a little better by November 2024, but that the long-term shortage will be in effect for another 18-24 months.

    This seems to be the case. I saw my oncologist today, and he said that many of his patients are finding it a *bit* easier to get hold of Creon these days. This tallies with my experience, and a few weeks ago I was in a pharmacy in Europe that had Creon in supply. So one hopes that we're entering an easier era. Let's see!

  • I received a message from my GP/pharmacy yesterday, saying that they're currently unable to get hold of Creon. This is first time in a few months that it's been this bad, and this article makes things sound not good.

    pharmaceutical-journal.com/.../taking-its-toll-the-global-pancreatic-enzyme-shortage

    I've emailed my MP (again) about this. How are other people doing?

  • I’m so sorry to hear that Luke. Do you have any Creon at all?

    I was able to get a prescription fully filled where I live, which is the first time in over 6 months that they were able to give me all the Creon on my prescription. I’m still taking a reduced amount though as they told me that supplies are still very inconsistent at the moment.

    I also only heard back from one of my regional MSPs. I think I’m going to contact them again and send them the article you’ve linked. It’s all very worrying.

  • Isn't it just? I've got enough for the rest of the month, thank you - but I'm hugely concerned about the next year or so. As I've banged on about before, I think we just have to keep pestering them. What worries me is that now it's a global issue rather than a national one.

  • And, to anyone who doesn't know of this service (I've only just discovered it!), you can check stock at local branches of Boots here:

    www.boots.com/.../

  • I am experiencing difficulties in repeat supplies in Co.Durham.England

  • I just spoke to a pharmacist who didn't sound optimistic. Our only hope is to get the subject as much coverage as we can, I think. Cliffy, do use that Boots link to see if there's any near you.